External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home Neuroscience AAN 2026
Roche and Genentech at

AAN 2026

April 18 - April 22
Chicago, USA / Virtual (Hybrid)
aan.com
We will be contributing to topics related to
Neuroscience Immunology
Add to calendar
Share feedback
Share page
-
Agenda
Medical Materials
08:54 PM
Duration 15mins Chicago, USA
Preservation of Ambulation and Hand Function at Healthy-Control Levels With First-Line Treatment With Ocrelizumab: Six-Year Findings From the ENSEMBLE Trial
Robert A Bermel, Ralph HB Benedict, Thomas Berger, Ludo Vanopdenbosch, Trygve Holmoy, Suzanne Moore, Licinio Craveiro, Joep Killestein
Neuroscience | Multiple Sclerosis

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
04:45 PM
Duration 60mins Chicago, USA
Beyond motor function in adults with spinal muscular atrophy (SMA): A systematic literature review of real-world outcomes with risdiplam
Carol Jean Guittari
Neuroscience | Spinal Muscular Atrophy

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 60mins Chicago, USA
Real-world motor function outcomes with risdiplam in Types 2 and 3 SMA: A systematic literature review and meta-analysis
Carol Jean Guittari
Neuroscience | Spinal Muscular Atrophy

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 30mins Chicago, USA
Patients' Knowledge and Attitudes Toward Serum Neurofilament Light Chain Testing in Early-stage Relapsing-remitting Multiple Sclerosis
Elena García-Arcelay, Inés González-Suárez, Jacobo Caruncho, Antonio Candeliere-Merlicco, Aida Orviz, Jesús Martín-Martínez, Raquel Piñar, Elena Álvarez-Rodríguez, Eva Pacheco, Laura Borrega, Ignacio Casanova, Ana B Caminero, José L Sánchez-Menoyo, Montserrat Gómez-Gutiérrez, Olga Carmona, Carmen Calles, Miguel A Hernández, Pablo López-Muñoz, Jorge Mauriño, Ángel Pérez-Sempere
Neuroscience | Multiple Sclerosis

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
10:00 PM
Duration 30mins Chicago, USA
OUTSMARTING THERAPEUTIC INERTIA: CAN CHATGPT-4O BEAT NEUROLOGISTS IN MULTIPLE SCLEROSIS AND NEUROMYELITIS OPTICA SPECTRUM DISORDER CARE?
Elena García-Arcelay, Rocío Gómez-Ballesteros, Aleix Solanes, Enric Monreal, María Sepúlveda, Ángel Pérez Sempere, Miguel Ángel Hernández, Juan Pablo Cuello, Gary Álvarez-Bravo, Eduardo Agüera, Javier Riancho, Jorge Maurino, Gustavo Saposnik
Neuroscience | Neuromyelitis Optica

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
01:00 PM
Duration 60mins Chicago, USA
Week 96 Analysis of the OCARINA II Study Characterizing Subcutaneous Ocrelizumab in Patients With Relapsing or Primary Progressive Multiple Sclerosis
Caroline Giacobino, Catarina Figueiredo, Diego Centonze, Dusanka Zecevic, Eva Krzystanek, Jay Azmi, Krzysztof Selmaj, Lawrence Goldstick, Scott Newsome, Susanne Clinch
Neuroscience | Multiple Sclerosis

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
03:30 PM
Duration 15mins Chicago, USA
Safety and efficacy of satralizumab in patients with relapsing myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): Results from the phase 3 METEOROID trial
Michael Levy, Eoin P. Flanagan, Tania Kümpfel, Romain Marignier, Kazuo Fujihara, Cheryl Hemingway, Daniela Stokmaier, Gaëlle Klingelschmitt, H.-Christian von Büdingen, Li Li, Sayuri Tanaka, Friedemann Paul
Immunology | Autoimmune disease

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
11:09 PM
Duration 15mins Chicago, USA
Efficacy and Safety of Fenebrutinib vs Teriflunomide in Relapsing Multiple Sclerosis: Results of the FENhance 1 and 2 Studies
Oh, Jiwon; Bar-Or, Amit; Giovannoni, Gavin; Sormani, Maria Pia; Weber, Martin S.; Stoll, Sharon; Nicholas, Jacqueline A.; von Büdingen, H. -Christian; Decker-Palmer, Marquita; Loukitcheva, Anastasia; Triyatni, Miriam; Hu, Nan; Ratchford, John N.; Napieralski, Julie; Goodyear, Alexandra; Kappos, Ludwig; Hauser, Stephen L.
Neuroscience | Multiple Sclerosis

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
06:00 PM
Duration 15mins Chicago, USA
ORATORIO-HAND: Results of the Primary Analysis of Ocrelizumab vs Placebo in Primary Progressive Multiple Sclerosis, Including Older Patients and Those With More Advanced Disease
Jiwon Oh, Gavin Giovannoni, Laura Airas, Riley Bove, Gary R Cutter, Jeremy Hobart,​ Jens Kuhle, Xavier Montalban, Carmen Tur, Jerry S Wolinsky, Hans-Martin Schneble, ​Anna Baldinotti, Ulrike Bonati, Caroline Giacobino, Qing Wang, Ke Yang
Neuroscience | Multiple Sclerosis

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
06:12 PM
Duration 15mins Chicago, USA
Humoral Vaccine Responses and 1-Year Follow-Up of Infants Potentially Exposed to Ocrelizumab During Pregnancy and Breastfeeding: Final Analyses of the Prospective, Multicenter, Open-Label, Phase IV Studies MINORE and SOPRANINO
Agne Kazlauskaite, Anna Shah, Celia Oreja Guevara, Carlo Pietrasanta, Daniela Goncalves Pereira Alves, Dina Jacobs, Edith Graham, Elisabeth Maillart, Riley Bove, Ruth Dobson, Sandra Vukusic, Thomas McElrath, Tobias Derfuss
Neuroscience | Multiple Sclerosis

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
06:36 PM
Duration 15mins Chicago, USA
Efficacy and Safety of Fenebrutinib vs Ocrelizumab in Primary Progressive Multiple Sclerosis: Primary Results of the Phase III FENtrepid Study
Bar-Or, Amit; Oh, Jiwon; Giovannoni, Gavin; Sormani, Maria Pia; Weber, Martin S; Stoll, Sharon; Nicholas, Jacqueline A; von Büdingen, H.-Christian; Lopez, Jon; Roberts, Louise; Triyatni, Miriam; Qi, Qi; Ratchford, Jack; Napieralski, Julie; Goodyear, Alexandra; Hauser, Stephen L; Kappos, Ludwig
Neuroscience | Multiple Sclerosis

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
06:48 PM
Duration 15mins Chicago, USA
Efficacy and Safety of Ocrelizumab Compared With Fingolimod in Pediatric-Onset Relapsing-Remitting MS: Results of the Phase III OPERETTA 2 Study
Brenda Banwell, Katarzyna Kotulska, Kevin Rostásy, Kumaran Deiva, Henry Sato, Massimo Filippi, Tanuja Chitnis, Maria Pia Sormani, Lauren Krupp, Amit Bar-Or, Joanna Evershed, Bouchra El Azzouzi, Qing Wang, Chien-Ju Lin, Alexandra Hogea, Hans-Martin Schneble, Corinne Manlius, Emmanuelle Waubant
Neuroscience | Multiple Sclerosis

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Coming soon

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.